Table 3 Different applications of acoustofluidic separation
Separated samples | Flow rate | Recovery rate (%) | Purity (%) | Viability (%) |
|---|---|---|---|---|
Blood cells from plasma1100 | 0.17 mL/min | 95 | 98 | – |
Platelets from RBCs19 | 0.4 mL/min | 99 | – | – |
Platelets from WBCs102 | 20 μL/min | 98 | – | 98 |
WBCs from RBCs105 | 5 μL/min | 88 | 54 | – |
Prostate cancer cells (DU145, PC3, and LNCaP) from WBCs111 | 70 μL/min | 72.5–93.9 | 79.6–99.7 | – |
CTCs from WBCs12 | 20 μL/min | >83 | – | 90.4 ± 4.7 |
Live MCF-7, N2a, and hESCs from dead ones114 | 100 μL/min | 49.7 ± 7.1 | 97.5 ± 2.5 | – |
Inflammatory cells from liquefied sputum117 | 10 μL/min | 83.9 ± 5.1 | – | 87.1 ± 8.9 |
Escherichia coli from blood cells121 | 4.5 μL/min | – | 95.65 | – |
Exosomes from whole blood13 | 4 μL/min | 82.4 | 98.4 | – |
100 nm particles from 300 nm particles132 | 1.8 μL/min | 86.3 | – | – |
Encapsulated cells from empty alginate beads144 | 8 μL/min | 97 | >98 | 85 |
